Effects of Z-300, a new histamine H2-receptor antagonist, on mucin biosynthesis in rat gastric mucosa. 1994

T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
Department of Biochemistry, Kitasato University School of Medicine, Kanagawa, Japan.

We examined the effects of Z-300 (N-[3-[3- (piperidinomethyl)phenoxy]propyl]-2-(2-hydroxy-ethyl-1-thio)acetam ido.2- (4-hydroxy benzoyl)benzoate), a newly-synthesized selective histamine H2-receptor antagonist, on mucin in rat gastric mucosa. Deep corpus mucin content increased significantly to 127% of the control after the administration of 30 mg/kg of Z-300, whereas that in the antral mucosa did not increase. The addition of Z-300 significantly increased [3H]-labeled mucin in the corpus region. In the antrum, biosynthetic activity showed no significant change by 10(-8)-10(-5) M of Z-300. These results suggest that Z-300 not only inhibits acid secretion but may also promote gastric mucus metabolism in the corpus region.

UI MeSH Term Description Entries
D008297 Male Males
D009077 Mucins High molecular weight mucoproteins that protect the surface of EPITHELIAL CELLS by providing a barrier to particulate matter and microorganisms. Membrane-anchored mucins may have additional roles concerned with protein interactions at the cell surface. Mucin
D009924 Organ Culture Techniques A technique for maintenance or growth of animal organs in vitro. It refers to three-dimensional cultures of undisaggregated tissue retaining some or all of the histological features of the tissue in vivo. (Freshney, Culture of Animal Cells, 3d ed, p1) Organ Culture,Culture Technique, Organ,Culture Techniques, Organ,Organ Culture Technique,Organ Cultures
D010880 Piperidines A family of hexahydropyridines.
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D005753 Gastric Mucosa Lining of the STOMACH, consisting of an inner EPITHELIUM, a middle LAMINA PROPRIA, and an outer MUSCULARIS MUCOSAE. The surface cells produce MUCUS that protects the stomach from attack by digestive acid and enzymes. When the epithelium invaginates into the LAMINA PROPRIA at various region of the stomach (CARDIA; GASTRIC FUNDUS; and PYLORUS), different tubular gastric glands are formed. These glands consist of cells that secrete mucus, enzymes, HYDROCHLORIC ACID, or hormones. Cardiac Glands,Gastric Glands,Pyloric Glands,Cardiac Gland,Gastric Gland,Gastric Mucosas,Gland, Cardiac,Gland, Gastric,Gland, Pyloric,Glands, Cardiac,Glands, Gastric,Glands, Pyloric,Mucosa, Gastric,Mucosas, Gastric,Pyloric Gland
D005944 Glucosamine 2-Amino-2-Deoxyglucose,Dona,Dona S,Glucosamine Sulfate,Hespercorbin,Xicil,2 Amino 2 Deoxyglucose,Sulfate, Glucosamine
D006635 Histamine H2 Antagonists Drugs that selectively bind to but do not activate histamine H2 receptors, thereby blocking the actions of histamine. Their clinically most important action is the inhibition of acid secretion in the treatment of gastrointestinal ulcers. Smooth muscle may also be affected. Some drugs in this class have strong effects in the central nervous system, but these actions are not well understood. Antihistaminics, H2,H2 Receptor Blockader,Histamine H2 Antagonist,Histamine H2 Blocker,Histamine H2 Receptor Antagonist,Histamine H2 Receptor Antagonists,Histamine H2 Receptor Blockader,Histamine H2 Receptor Blockaders,Antagonists, Histamine H2,Blockaders, Histamine H2 Receptor,H2 Receptor Blockaders,Histamine H2 Blockers,Receptor Antagonists, Histamine H2,Receptor Blockaders, H2,Antagonist, Histamine H2,Blockader, H2 Receptor,Blockaders, H2 Receptor,Blocker, Histamine H2,Blockers, Histamine H2,H2 Antagonist, Histamine,H2 Antagonists, Histamine,H2 Antihistaminics,H2 Blocker, Histamine,H2 Blockers, Histamine,Receptor Blockader, H2
D000081 Acetamides Derivatives of acetamide that are used as solvents, as mild irritants, and in organic synthesis.
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
August 1999, Xenobiotica; the fate of foreign compounds in biological systems,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
April 1999, Xenobiotica; the fate of foreign compounds in biological systems,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
July 1992, Japanese journal of pharmacology,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
January 1986, European journal of clinical pharmacology,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
November 1994, Nihon yakurigaku zasshi. Folia pharmacologica Japonica,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
January 1984, European journal of clinical pharmacology,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
June 1989, Nihon Jinzo Gakkai shi,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
February 1990, Toxicology and applied pharmacology,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
February 2000, Xenobiotica; the fate of foreign compounds in biological systems,
T Ichikawa, and K Ishihara, and Y Ogata, and S Ohara, and K Saigenji, and K Hotta
January 1974, Surgical forum,
Copied contents to your clipboard!